VKTX: Viking Therapeutics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
438 institutions reported holding $2.93B of Viking Therapeutics Inc on Form 13F (415 the quarter before). 70 opened a new position and 50 sold out. Shares held by institutions: +3%.
| Largest holders | Shares | Value |
|---|---|---|
| FMR LLC | 6,335,756 | $247.16M |
| BlackRock, Inc. | 6,189,649 | $241.46M |
| STATE STREET CORP | 5,606,394 | $218.71M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,053,663 | $197.14M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,484,263 | $174.93M |
| TWO SIGMA INVESTMENTS, LP | 3,937,414 | $153.60M |
| MORGAN STANLEY | 3,486,040 | $135.99M |
| AMERIPRISE FINANCIAL INC | 2,156,083 | $84.11M |
| GEODE CAPITAL MANAGEMENT, LLC | 2,097,981 | $81.87M |
| AMERICAN CENTURY COMPANIES INC | 1,816,050 | $70.84M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.